Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Military to study better pain relief in battle zones

Abstract:
University of Michigan scientists win $1.3M grant to create and test nanoparticles that may deliver morphine to wounded soldiers faster and more safely

Military to study better pain relief in battle zones

ANN ARBOR, MI | Posted on July 30th, 2007

University of Michigan scientists have received a pilot grant of nearly $1.3 million from the Defense Advanced Research Projects Agency to test whether nanoparticles can solve a pressing problem in battle zones like Iraq: how to administer sustained, safe doses of the most effective painkillers to injured soldiers, long before they can reach expert medical help.

The ultimate goal is to develop tiny drug-bearing particles that a fellow soldier "or perhaps the injured soldier himself" could inject with a pen-like device, even in the heat of combat. That would solve one of the challenges now. Morphine, an effective painkiller that the military commonly uses for the acute pain of battle injuries, currently needs to be injected by skilled medical personnel and has to be monitored carefully to control its troublesome tendency to suppress normal breathing.

"This proposal provides an approach to achieve sustained, safe pain control on the battlefield," says the U-M research team's leader, James R. Baker, Jr., M.D., director of the Michigan Nanotechnology Institute for Medicine and Biological Sciences.

"It uses different medicines coupled to polymers to release drugs and antidotes to provide adequate pain relief while avoiding complications. If successful, it could markedly improve the treatment of soldiers in the field," says Baker, the Ruth Dow Doan Professor of Internal Medicine in the U-M Medical School.

The work could have a broad impact. In the war in Iraq, more than 26,900 U.S. soldiers have been wounded in action as of late July. It's known that battlefield pain, if not relieved adequately, can lead to post-traumatic stress disorders.

A large multidisciplinary team of U-M scientists will use the grant to design multipurpose nanoparticles and test how well they perform several tasks under simulated physiological conditions in the laboratory. Ultimately, they want the particles to be able to:

* control the release of morphine over extended periods before a soldier can be evacuated to a military acute care facility,

* continuously monitor the soldier�s breathing and if needed, release a drug called Naloxone that is used to counter morphine�s effects on breathing.

The team, which includes synthetic, analytical and medicinal chemists, will expand on the use of dendrimer platforms, a technology previously developed at the U-M. They will design ultra-small polymer particles called dendrimers capable of carrying morphine and Naloxone into the body and releasing them in controlled amounts. They will develop sensors that the dendrimers will also carry to monitor a soldier's respiration and trigger Naloxone release, or halt it, as needed.

If the concept proves successful after the first year of in vitro studies, Baker and his team want to apply for continued DARPA funding to proceed with animal and eventually human studies.

Other U-M team members include Abraham F. L. Vanderspek, M.D., associate professor of anesthesiology; Brent Ward, MD, DDS, FACS, assistant professor of oral and maxillofacial surgery and program director of Oncologic Maxillofacial/Head & Neck Surgery; Xue-min Cheng, Ph.D., research associate professor, Department of Internal Medicine and M-NiMBS; a medicinal chemist, Rameshwer Shukla, Ph.D., who is a research investigator in the Department of Internal Medicine and M-NiMBS; a medicinal chemist, Xiangyang Shi, Ph.D., who is a research investigator in the Department of Internal Medicine and M-NiMBS; a polymer chemist, Baohua Huang, Ph.D., who is a research investigator in the Department of Internal Medicine and M-NiMBS; a polymer chemist, Xiangdong Bi, Ph.D., Department of Internal Medicine and M-NiMBS; an organic chemist, Mark M. Banaszak Holl, Ph.D., professor of chemistry, applied physics and biophysics in the U-M College of Literature, Science, and the Arts, and of macromolecular science and engineering in the U-M College of Engineering; Ankur Desai, M.S., Department of Internal Medicine and M-NiMBS; an analytical chemist, Thommey P. Thomas, Ph.D., research assistant professor, Department of Internal Medicine and M-NiMBS; Bradford G. Orr, Ph.D., professor of physics in LS&A, director of the Academic Program in Applied Physics, and associate director of M-NiMBS; Alina Kotlyar, M.S., Department of Internal Medicine and M-NiMBS; and Thomas Dunham, B.S., of U-M Maxillofacial Surgery.

For more information on the U-M Nanotechnology Institute for Medicine and Biological Sciences, visit http://www.nano.med.umich.edu/

Funding for the study comes from the Defense Advanced Research Projects Agency, part of the U.S. Department of Defense.

Patent applications have been filed on related U-M dendrimer inventions, which have been exclusively licensed to Avidimer Therapeutics, an Ann Arbor based biotech company in which Dr. Baker has a financial interest.

####

About University of Michigan Health System
We are among the country's top institutions in federally funded research. We are prominent in the pursuit of discovery, in the translation of pioneering breakthroughs to the clinical and business settings, and in the dissemination of new knowledge to health care providers and the public at large.

For more information, please click here

Contacts:
Anne Rueter

734-764-2220

Copyright © University of Michigan Health System

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014

ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014

An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014

Iran Exports Nanodrugs to Syria November 24th, 2014

Announcements

Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014

ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014

An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014

Cooling with the coldest matter in the world November 24th, 2014

Patents/IP/Tech Transfer/Licensing

Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program November 17th, 2014

First genetic-based tool to detect circulating cancer cells in blood: NanoFlares light up individual cells if breast cancer biomarker is present November 17th, 2014

Ki-Bum Lee Patents Technology To Advance Stem Cell Therapeutics November 13th, 2014

'Direct writing' of diamond patterns from graphite a potential technological leap November 5th, 2014

Military

NRL Scientists Discover Novel Metamaterial Properties within Hexagonal Boron Nitride November 20th, 2014

Two sensors in one: Nanoparticles that enable both MRI and fluorescent imaging could monitor cancer, other diseases November 18th, 2014

Researchers create & control spin waves, lifting prospects for enhanced info processing November 17th, 2014

Penn engineers efficiently 'mix' light at the nanoscale November 17th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

SUNY Poly Student Awarded Fellowship with the U.S. Department of Energy's Postgraduate Research Program: Ph.D. Candidate Accepts Postmaster's Appointment To Conduct Research At Albany NanoTech Complex November 13th, 2014

MEMS Industry Group's 10th Annual Executive Conference Showcases Rapid Innovation in MEMS/Sensors: Emphasizes Spirit of Collaboration, Supporting First Open-Source Algorithm Community, New Standardization Efforts November 10th, 2014

Microrockets fueled by water neutralize chemical and biological warfare agents October 29th, 2014

New nanodevice to improve cancer treatment monitoring October 27th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE